Insider Shareholders with Direct Ownership of Gt Biopharma, Inc. (GTBP)
This section provides a comprehensive overview of the insiders with direct ownership of Gt Biopharma, Inc. (GTBP). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
GT Biopharma, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 0 | 780,000 | 3,720,000 $6.51 Million | 8 |
Dec 22, 2020
Reduced 1.27%
|
|
|
Michael Martin Breen
Executive Chairman/Interim CEO |
856,218 | 0 | 856,218 $1.5 Million | 5 |
Aug 11, 2023
Added 18.94%
|
|
Bruce Wendel
Director |
352,655 | 0 | 352,655 $617,146 | 3 |
Feb 16, 2021
Added 49.64%
|
|
Gregory Berk
Pres. of R&D, CMO |
278,058 | 0 | 278,058 $486,601 | 1 |
Feb 16, 2021
Added 50.0%
|
|
Manu Ohri
CFO & Secretary |
300,000 | 300,000 | 0 $0 | 4 |
Jul 15, 2022
Reduced 100.0%
|